Anupam Rasayan India Ltd
Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]
- Market Cap ₹ 9,291 Cr.
- Current Price ₹ 846
- High / Low ₹ 1,250 / 782
- Stock P/E 60.2
- Book Value ₹ 223
- Dividend Yield 0.30 %
- ROCE 12.6 %
- ROE 8.82 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.80 times its book value
- Company has a low return on equity of 8.46% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -4.14%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|
502 | 529 | 811 | 1,074 | 1,602 | 1,554 | |
408 | 394 | 617 | 769 | 1,171 | 1,149 | |
Operating Profit | 93 | 135 | 194 | 305 | 431 | 405 |
OPM % | 19% | 25% | 24% | 28% | 27% | 26% |
19 | 11 | 26 | 8 | 10 | 42 | |
Interest | 24 | 45 | 69 | 31 | 63 | 84 |
Depreciation | 23 | 29 | 52 | 60 | 71 | 77 |
Profit before tax | 66 | 72 | 100 | 222 | 308 | 287 |
Tax % | 24% | 26% | 30% | 31% | 30% | |
49 | 53 | 70 | 152 | 217 | 200 | |
EPS in Rs | 9.85 | 10.64 | 7.04 | 15.18 | 16.84 | 14.33 |
Dividend Payout % | 0% | 0% | 7% | 7% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 45% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 51% |
TTM: | -9% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 15% |
1 Year: | -19% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 8% |
Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|
Equity Capital | 50 | 50 | 100 | 100 | 107 | 108 |
Reserves | 432 | 515 | 1,473 | 1,627 | 2,265 | 2,332 |
Preference Capital | 25 | 28 | 0 | 0 | 0 | |
670 | 819 | 423 | 836 | 822 | 1,117 | |
170 | 280 | 301 | 327 | 584 | 686 | |
Total Liabilities | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,243 |
681 | 977 | 1,115 | 1,202 | 1,417 | 1,449 | |
CWIP | 191 | 101 | 43 | 44 | 120 | 296 |
Investments | 0 | 0 | 0 | 149 | 67 | 85 |
451 | 586 | 1,140 | 1,496 | 2,173 | 2,413 | |
Total Assets | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,243 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
39 | 95 | 1 | -171 | 292 | |
-250 | -178 | -193 | -412 | -523 | |
206 | 102 | 416 | 384 | 371 | |
Net Cash Flow | -6 | 19 | 224 | -199 | 140 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Debtor Days | 88 | 89 | 92 | 95 | 95 |
Inventory Days | 277 | 515 | 530 | 852 | 483 |
Days Payable | 105 | 226 | 215 | 225 | 167 |
Cash Conversion Cycle | 260 | 379 | 408 | 722 | 410 |
Working Capital Days | 168 | 185 | 233 | 328 | 253 |
ROCE % | 9% | 10% | 11% | 13% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 15 Apr
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 15 Apr
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 12 Apr
-
Compliance Certificate For The Financial Year Ended March 31, 2024
10 Apr - Compliance Certificate for the financial year ended March 31, 2024 under Regulation 7(3) of SEBI (LODR) Regulations, 2015, is enclosed herewith.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2 Apr - Press release which shall be issued by the Company today i.e., April 02, 2024.
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
Life Science Specialty Chemicals (~92% revenues)
Under the vertical, the company offers various specialty chemicals across various categories :-
a. Agrochemicals - insecticides, fungicides, herbicides and plant growth regulators.
b. Personal Care - antibacterial and ultraviolet protection intermediates and ingredients.
c. Pharmaceuticals - developing of intermediates and key starting materials for APIs.[1]